Trials / Conditions / Lymphoma, Extranodal NK-T-Cell

Lymphoma, Extranodal NK-T-Cell

16 registered clinical trials studyying Lymphoma, Extranodal NK-T-Cell — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Selinexor, Anti-PD-1 Antibody Plus Golidocitinib in R/R NKTCL NCT06573138	Ruijin Hospital	Phase 2
Active Not Recruiting	Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma NCT04417166	International Extranodal Lymphoma Study Group (IELSG)	Phase 2
Unknown	Avelumab in Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma[AVENT STUDY] NCT03439501	Samsung Medical Center	Phase 2
Unknown	GLIDE Regimen Followed by ASCT for Aggressive NK/T Cell Lymphoma NCT03154918	Sichuan University	Phase 2
Completed	T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas NCT03049449	National Cancer Institute (NCI)	Phase 1
Unknown	18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Natural Killer/T-cell Lymphoma NCT03051555	Peking University Cancer Hospital & Institute	N/A
Unknown	Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Natural Killer/T-cel NCT03051542	Peking University Cancer Hospital & Institute	N/A
Recruiting	Allogeneic Stem Cell Transplantation in Relapsed/Refractory T-, NK/T-cell Lymphomas NCT02859402	Keimyung University Dongsan Medical Center	Phase 2
Unknown	Differences Between Chidamide Taken Daily and Twice a Week in Therapeutic Effect，Pharmacokinetics, Pharmacodyn NCT02878278	Huiqiang Huang	Phase 2
Unknown	AEDV Registry of Primary Cutaneous Lymphoma NCT03646422	Fundación Academia Española de Dermatología	—
Terminated	Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Earl NCT02359162	Sun Yat-sen University	Phase 3
Terminated	Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma NCT01948180	Cell Medica Ltd	Phase 2
Unknown	Combine GELOX With Concurrent Radiation Therapy for Patients With Stage IE/IIE ENKTL NCT02080234	Sun Yat-sen University	Phase 2
Unknown	MESA Treatment for NK/T Cell Lymphoma NCT01933282	Air Force Military Medical University, China	Phase 2
Terminated	P-Gemox Regimen as First-line Chemotherapy in NK/T Lymphoma Patiens NCT02533323	Sun Yat-sen University	Phase 2
Completed	Campath-1H and EPOCH to Treat Non-Hodgkin's T- and NK-Cell Lymphomas NCT00069238	National Cancer Institute (NCI)	Phase 2